AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15233977 — intervention group
Group type: EXPERIMENTAL
Intervention: nebivolol
Number of subjects: 550
Study 11324774 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management training
Number of subjects: 131
Study 11324774 — intervention group
Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 131
Study 11324774 — intervention group
Group type: COMPARATOR
Intervention: Standard care control group
Number of subjects: 131
Study 9436810 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG)
Number of subjects: 8
Study 9436810 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 8
Study 8498168 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial oculomotor test
Number of subjects: 40
Study 8498168 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up oculomotor test after 15 months
Number of subjects: 40
Study 8498168 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms in patients with oculomotor dysfunction
Number of subjects: 40
Study 8498168 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms in patients with normal test results
Number of subjects: 40
Study 30786030 — intervention group
Group type: EXPERIMENTAL
Intervention: Provox Luna system
Number of subjects: 46
Study 30786030 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 46
Study 29966802 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet intervention (delivered by dietitians) for 6 months
Number of subjects: 1032
Study 29966802 — intervention group
Group type: COMPARATOR
Intervention: Standard-care low-fat diet
Number of subjects: 1032
Study 26679329 — intervention group
Group type: EXPERIMENTAL
Intervention: KAAA (KEx) supplementation
Number of subjects: 16
Study 26679329 — intervention group
Group type: COMPARATOR
Intervention: Placebo (CEx) supplementation
Number of subjects: 16
Study 24976417 — intervention group
Group type: EXPERIMENTAL
Intervention: Purported weight loss supplement (placebo)
Number of subjects: 0
Study 24976417 — intervention group
Group type: COMPARATOR
Intervention: Known placebo
Number of subjects: 0
Study 22551105 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (target INR 2.0 to 3.5)
Number of subjects: 2305
Study 22551105 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (325 mg per day)
Number of subjects: 2305
Study 22551105 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 2305
Study 22551105 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 2305
Study 20345865 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg daily
Number of subjects: 3229
Study 20345865 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3229
Study 18388082 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of collateral circulation
Number of subjects: 114
Study 16149737 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpine butter
Number of subjects: 16
Study 16149737 — intervention group
Group type: COMPARATOR
Intervention: Margarine
Number of subjects: 16
Study 12473419 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal drug abuse prevention program
Number of subjects: 758
Study 12473419 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no intervention)
Number of subjects: 758
Study 10544864 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide HCl 0.5 mg/5 mL
Number of subjects: 258
Study 10544864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258
Study 8669504 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone condition
Number of subjects: 392
Study 8669504 — intervention group
Group type: COMPARATOR
Intervention: Mail condition
Number of subjects: 392
Study 2003077 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung hyperinflation breaths at tidal volumes of 12cc/kg, 14cc/kg, 16cc/kg, and 18cc/kg of lean body weight followed by suctioning
Number of subjects: 34
Study 6344540 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (10(‐5) ‐ 10(‐3) moles/l)
Number of subjects: 18
Study 6344540 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid, indomethacin, tolfenamic acid (anti-prostaglandins)
Number of subjects: 18
Study 31042791 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased opacity of CMV retinitis lesions
Number of subjects: 299
Study 31042791 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe opacity (scores 5, 6) in eyes with active disease
Number of subjects: 299
Study 31042791 — intervention group
Group type: EXPERIMENTAL
Intervention: Opacity scoring
Number of subjects: 299
Study 29696920 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment group (acupuncture + modified formula of buzhong yiqi tang and cizhu wan)
Number of subjects: 60
Study 29696920 — intervention group
Group type: COMPARATOR
Intervention: Herbal medicine group (modified formula of buzhong yiqi tang and cizhu wan only)
Number of subjects: 60
Study 27463259 — intervention group
Group type: EXPERIMENTAL
Intervention: Fried French Fries
Number of subjects: 33
Study 27463259 — intervention group
Group type: COMPARATOR
Intervention: Baked Potato
Number of subjects: 33
Study 27463259 — intervention group
Group type: COMPARATOR
Intervention: Mashed Potato
Number of subjects: 33
Study 27463259 — intervention group
Group type: COMPARATOR
Intervention: Potato Wedges
Number of subjects: 33
Study 27463259 — intervention group
Group type: COMPARATOR
Intervention: Pasta Control
Number of subjects: 33
Study 25261968 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-gene Recurrence Score assay
Number of subjects: 0
Study 22950660 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal support with micronized progesterone (P)
Number of subjects: 9
Study 22950660 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal support with progesterone plus 17‐beta‐estradiol (P + E)
Number of subjects: 9
Study 22950660 — intervention group
Group type: COMPARATOR
Intervention: No luteal-phase support
Number of subjects: 9
Study 19631048 — intervention group
Group type: EXPERIMENTAL
Intervention: First Step First Bite Program
Number of subjects: 22
Study 19631048 — intervention group
Group type: COMPARATOR
Intervention: First Step Program
Number of subjects: 22
Study 17211855 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RGZ)
Number of subjects: 17
Study 17211855 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (PGZ)
Number of subjects: 17
Study 15356026 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (PIO), 45 mg/d for 4 months
Number of subjects: 23
Study 15356026 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 11250664 — intervention group
Group type: EXPERIMENTAL
Intervention: Low lactose milk powder (twice daily for seven weeks)
Number of subjects: 47
Study 11250664 — intervention group
Group type: COMPARATOR
Intervention: No supplement (control group)
Number of subjects: 47
Study 11250664 — intervention group
Group type: EXPERIMENTAL
Intervention: Low lactose milk powder
Number of subjects: 47
Study 9549654 — intervention group
Group type: EXPERIMENTAL
Intervention: (R)-ketoprofen 100 mg
Number of subjects: 177
Study 9549654 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 1,000 mg
Number of subjects: 177
Study 9549654 — intervention group
Group type: EXPERIMENTAL
Intervention: (R)-ketoprofen 25 mg
Number of subjects: 177
Study 9549654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study 7989710 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoprophylaxis (group 2)
Number of subjects: 56
Study 7989710 — intervention group
Group type: COMPARATOR
Intervention: No immunoprophylaxis (group 1)
Number of subjects: 56
Study 7989710 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with co-existent hepatitis delta virus infection or in group 2
Number of subjects: 56
Study 7989710 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent patients with recurrence
Number of subjects: 56
Study 7989710 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with coexistent delta infection and lower levels of circulating HBV DNA
Number of subjects: 56
Study 7989710 — intervention group
Group type: EXPERIMENTAL
Intervention: Retransplantation for associated graft injury
Number of subjects: 56
Study 2590265 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg ibopamine
Number of subjects: 12
Study 2590265 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 12
Study 2590265 — intervention group
Group type: EXPERIMENTAL
Intervention: Food
Number of subjects: 12
Study 31922284 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 31200429 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation
Number of subjects: 0
Study 31200429 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 0
Study 28027975 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic simulation curriculum (4 dVSS training tasks: camera clutching 1, suture sponge 1 and 2, and tubes)
Number of subjects: 35
Study 28027975 — intervention group
Group type: COMPARATOR
Intervention: No further training (control group)
Number of subjects: 35
Study 25959323 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical keypad
Number of subjects: 0
Study 25959323 — intervention group
Group type: COMPARATOR
Intervention: Touch screen device
Number of subjects: 0
Study 25959323 — intervention group
Group type: EXPERIMENTAL
Intervention: Texting with 1 hand/thumb
Number of subjects: 0
Study 25959323 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased touch screen size
Number of subjects: 0
Study 23846569 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal screening
Number of subjects: 9572
Study 23846569 — intervention group
Group type: COMPARATOR
Intervention: Targeted screening
Number of subjects: 9572
Study 21851343 — intervention group
Group type: EXPERIMENTAL
Intervention: Stethoscope-guided cuff inflation
Number of subjects: 50
Study 21851343 — intervention group
Group type: COMPARATOR
Intervention: Standard 'just seal' cuff inflation
Number of subjects: 50
Study 19485584 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (antidepressant medication)
Number of subjects: 332
Study 19485584 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 332
Study 19485584 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of fluoxetine and cognitive-behavioral therapy
Number of subjects: 332
Study 19485584 — intervention group
Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 332
Study 16825684 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal replacements (2 meal replacements/day, 4904.4 kJ) during an 8-week weight-loss regimen
Number of subjects: 43
Study 16825684 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate restriction (<120 g/d) or fat restriction (<50 g/d) during a 6-month weight-maintenance regimen
Number of subjects: 43
Study 14615297 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects (control group)
Number of subjects: 0
Study 14615297 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with left posterior cerebral artery infarcts
Number of subjects: 0
Study 14615297 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter-by-letter reading strategy
Number of subjects: 0
Study 10809473 — intervention group
Group type: EXPERIMENTAL
Intervention: Education of patients and family members about pain control, monitoring of patients' pain, and feedback about pain with treatment suggestions to nurses and physicians
Number of subjects: 0
Study 10809473 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 0
Study 8996575 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide phosphate plus cisplatin
Number of subjects: 120
Study 8996575 — intervention group
Group type: COMPARATOR
Intervention: Etoposide plus cisplatin
Number of subjects: 120
Study 1600494 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide + Flutamide
Number of subjects: 603
Study 1600494 — intervention group
Group type: COMPARATOR
Intervention: Leuprolide
Number of subjects: 603
Study 2864793 — intervention group
Group type: EXPERIMENTAL
Intervention: mianserin 30‐60 mg
Number of subjects: 62
Study 2864793 — intervention group
Group type: COMPARATOR
Intervention: clomipramine 75‐150 mg
Number of subjects: 62
Study 31986905 — intervention group
Group type: EXPERIMENTAL
Intervention: Volunteering intervention (four 1-hour sessions)
Number of subjects: 384
Study 31986905 — intervention group
Group type: COMPARATOR
Intervention: Active control (promoting physical activity)
Number of subjects: 384
Study 28943384 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 4010
Study 28943384 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic patients
Number of subjects: 4010
Study 28441966 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegafur-uracil maintenance therapy for 1 year after adjuvant oxaliplatin-based regimen.
Number of subjects: 546
Study 28441966 — intervention group
Group type: COMPARATOR
Intervention: Observation arm (no treatment).
Number of subjects: 546
Study 26333880 — intervention group
Group type: EXPERIMENTAL
Intervention: FM remote microphone system
Number of subjects: 16
Study 26333880 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 MHz remote microphone system
Number of subjects: 16
Study 26333880 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.4 GHz remote microphone system
Number of subjects: 16
Study 26333880 — intervention group
Group type: EXPERIMENTAL
Intervention: Bluetooth paired with near-field magnetic induction remote microphone system
Number of subjects: 16
Study 26333880 — intervention group
Group type: COMPARATOR
Intervention: Hearing aids alone
Number of subjects: 16
Study 24244635 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART+maraviroc
Number of subjects: 97
Study 24244635 — intervention group
Group type: COMPARATOR
Intervention: HAART
Number of subjects: 97
Study 21159787 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 16
Study 21159787 — intervention group
Group type: COMPARATOR
Intervention: Corn oil
Number of subjects: 16
Study 18347654 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (2000 mg/d for 7-9 days)
Number of subjects: 17
Study 18347654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 17009837 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg telmisartan
Number of subjects: 36
Study 17009837 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg telmisartan
Number of subjects: 36
Study 12713080 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mmol/L bicarbonate/10 mmol/L lactate peritoneal dialysis solution
Number of subjects: 40
Study 12713080 — intervention group
Group type: COMPARATOR
Intervention: 35 mmol/L lactate solution
Number of subjects: 40
Study 10669364 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea (500 mg/day)
Number of subjects: 0
Study 10669364 — intervention group
Group type: EXPERIMENTAL
Intervention: Stavudine-lamivudine
Number of subjects: 0
Study 9052559 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraceliac aortic clamping (SCC)
Number of subjects: 18
Study 9052559 — intervention group
Group type: COMPARATOR
Intervention: Infrarenal clamping (IRC)
Number of subjects: 18
Study 8397839 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Precision Full Head soft toothbrush
Number of subjects: 101
Study 8397839 — intervention group
Group type: COMPARATOR
Intervention: Crest Complete soft toothbrush
Number of subjects: 101
Study 3539129 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic drug preparation C (i.v. injections over 5 days)
Number of subjects: 39
Study 3539129 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic drug preparation D (i.v. injections over 5 days)
Number of subjects: 39
Study 3539129 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (i.v. injections over 5 days)
Number of subjects: 39
Study 31608930 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin infusion (1 pmol/min × kg)
Number of subjects: 8
Study 31608930 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin infusion
Number of subjects: 8
Study 31608930 — intervention group
Group type: COMPARATOR
Intervention: Glucose-dependent insulinotropic polypeptide (positive control)
Number of subjects: 8
Study 31608930 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraluminal glucose
Number of subjects: 8
Study 29526831 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexketoprofen (50 mg in 100 mL normal saline)
Number of subjects: 99
Study 29526831 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (1 g in 100 mL normal saline)
Number of subjects: 99
Study 27126852 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health literacy curriculum integrated into grade 11 and 12 'Healthy Living' courses, delivered by teachers.
Number of subjects: 534
Study 27126852 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no intervention).
Number of subjects: 534
Study 24576912 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive FAST test in EMCC
Number of subjects: 900
Study 24576912 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive FAST test in ambulances
Number of subjects: 900
Study 24576912 — intervention group
Group type: COMPARATOR
Intervention: Negative FAST test in EMCC
Number of subjects: 900
Study 24576912 — intervention group
Group type: COMPARATOR
Intervention: Negative FAST test in ambulances
Number of subjects: 900
Study 24576912 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive FAST test in nonstroke diagnosis from EMCC
Number of subjects: 900
Study 22551385 — intervention group
Group type: EXPERIMENTAL
Intervention: Full guided implant surgery (template based guided cavity preparation and guided implant insertion)
Number of subjects: 5
Study 22551385 — intervention group
Group type: COMPARATOR
Intervention: Half-guided implant surgery (template based guided cavity preparation and free-handed, manual implant insertion)
Number of subjects: 5
Study 21999723 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-caloric carbonated beverage (B+CO2)
Number of subjects: 10
Study 21999723 — intervention group
Group type: COMPARATOR
Intervention: Non-caloric beverage without CO2 (B‐CO2)
Number of subjects: 10
Study 21999723 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 10
Study 18454662 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline microspheres (1 mg)
Number of subjects: 32
Study 18454662 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine gel
Number of subjects: 32
Study 16567269 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized menu suggestions and education on food exchanges
Number of subjects: 70
Study 16567269 — intervention group
Group type: COMPARATOR
Intervention: Traditional patient education method
Number of subjects: 70
Study 14513159 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete AED withdrawal (Group 1)
Number of subjects: 94
Study 14513159 — intervention group
Group type: COMPARATOR
Intervention: Partial AED withdrawal (Group 2)
Number of subjects: 94
Study 14513159 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 94
Study 10737284 — intervention group
Group type: EXPERIMENTAL
Intervention: MUFA diet (extra-virgin olive oil)
Number of subjects: 23
Study 10737284 — intervention group
Group type: COMPARATOR
Intervention: PUFA diet (sunflower oil)
Number of subjects: 23
Study 9366815 — intervention group
Group type: EXPERIMENTAL
Intervention: UltraPulse laser system
Number of subjects: 28
Study 9366815 — intervention group
Group type: EXPERIMENTAL
Intervention: SilkTouch laser system
Number of subjects: 28
Study 9366815 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 28
Study 1543376 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin (Desmospray) for one month
Number of subjects: 55
Study 1543376 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin (Desmospray) for three months
Number of subjects: 55
Study 1543376 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin responsive enuretics
Number of subjects: 55
Study 1543376 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin non-responders
Number of subjects: 55
Study 1543376 — intervention group
Group type: COMPARATOR
Intervention: Non-enuretic control children
Number of subjects: 55
Study 3633416 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent dressings (Tegaderm® transparent dressing, 3M, St. Paul, MN) changed once a week (n = 188)
Number of subjects: 365
Study 3633416 — intervention group
Group type: COMPARATOR
Intervention: Paper tape dressings changed three times a week (n = 177)
Number of subjects: 365
Study 3633416 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent dressings
Number of subjects: 365
Study 3633416 — intervention group
Group type: COMPARATOR
Intervention: Paper tape dressings
Number of subjects: 365
Study 3633416 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent dressings worn up to 7 days
Number of subjects: 365
Study 29428326 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified definition for OSA (AHI 5-14.9 per hour with oxygen desaturation)
Number of subjects: 106
Study 29428326 — intervention group
Group type: COMPARATOR
Intervention: Classic definition for OSA (AHI ≥15)
Number of subjects: 106
Study 26795673 — intervention group
Group type: EXPERIMENTAL
Intervention: Facility-based aerobic exercise utilizing a portable stationary pedal exerciser
Number of subjects: 40
Study 26795673 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 24867512 — intervention group
Group type: EXPERIMENTAL
Intervention: Colinox® (combination of Simethicone and Bacillus coagulans)
Number of subjects: 52
Study 24867512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 22322738 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable (observational study)
Number of subjects: 1335
Study 20647174 — intervention group
Group type: EXPERIMENTAL
Intervention: Elimination diet based on IgG antibodies
Number of subjects: 30
Study 17875547 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) standard dose (10 mg/m2/week)
Number of subjects: 521
Study 17875547 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) higher dose (15 mg/m2/week or 30 mg/m2/week)
Number of subjects: 521
Study 17875547 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy children)
Number of subjects: 521